
Vipul C. Chitalia
Professor · Boston University School of Medicine
Credentials: · · · · ·
History
Research
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
ACS Central Science · 2021 · 214 citations
Nature Cell Biology · 2008 · First of 11 authors · 155 citations
Stromal endothelial cells directly influence cancer progression
Science Translational Medicine · 2011 · 136 citations

29 papers

22 papers · 3 as a resident

14 papers · 11 as a resident

12 papers

12 papers

11 papers · 11 as a resident
- EE
10 papers
- JR
8 papers · 4 as a resident
Grants
- 2024–2029
Role of Intravenous Ultrasound (IVUS) in Arteriovenous Hemodialysis Access Dysfunction
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.3M · Boston Medical Center
- 2023–2027
Disease-Specific Risk Factors for Thrombosis Following Vascular Interventions
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.7M · Boston Medical Center
- 2021–2027
The Boston University Kidney and Medical Engineering Program (BU-KIDMEP)
National Institute of Diabetes and Digestive and Kidney Diseases · R25
PI · $636.8K · Boston Medical Center
- 2022–2025
National Institute of Diabetes and Digestive and Kidney Diseases · R21
PI · $478.1K · Boston University (Charles River Campus)
Clinical trials
- 2027–2030
Anti-Interleukin-6 (IL6) in Calciphylaxis
Principal investigator · Not yet recruiting · Phase 1
Boston Medical Center
- 2021–2026
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
Principal investigator · Recruiting
Boston Medical Center



